Legend Biotech Announces CEO Transition
Legend Biotech announced that Ying Huang, Ph.D., has stepped down as CEO and Board member, remaining as an advisor through August for a smooth transition. Alan Bash, President of the CARVYKTI Business Unit, is appointed Interim CEO, while the Board starts a search for a permanent CEO. The company remains focused on advancing its commercial, clinica…